These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25856586)

  • 41. Highlights in lymphoma from the 2012 American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2013 Feb; 11(2 Suppl 3):6-23. PubMed ID: 23604200
    [No Abstract]   [Full Text] [Related]  

  • 42. Highlights in Lymphoma From the 60th American Society of Hematology Annual Meeting: Commentary.
    Herrera AF
    Clin Adv Hematol Oncol; 2019 Feb; 17 Suppl 4(2):20-23. PubMed ID: 31730577
    [No Abstract]   [Full Text] [Related]  

  • 43. Highlights in Graft-vs-Host Disease From the 60th American Society of Hematology Annual Meeting: Commentary.
    Jagasia M
    Clin Adv Hematol Oncol; 2019 Mar; 17 Suppl 6(3):16-18. PubMed ID: 31730585
    [No Abstract]   [Full Text] [Related]  

  • 44. Highlights in mantle cell lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Apr; 19 Suppl 13(4):1-20. PubMed ID: 35290295
    [No Abstract]   [Full Text] [Related]  

  • 45. Highlights in mantle cell lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 6(2):1-24. PubMed ID: 35343946
    [No Abstract]   [Full Text] [Related]  

  • 46. Highlights in CAR T-cell therapy from the 61st American Society of Hematology Annual Meeting: commentary.
    Jacobson CA
    Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 7(2):20-23. PubMed ID: 33843872
    [No Abstract]   [Full Text] [Related]  

  • 47. Highlights in chronic lymphocytic leukemia from the 63rd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2022 Jan; 20 Suppl 2(1):1-20. PubMed ID: 35343935
    [No Abstract]   [Full Text] [Related]  

  • 48. Highlights in graft-vs-host disease from the 63rd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2022 Jan; 20 Suppl 3(1):1-24. PubMed ID: 35343939
    [No Abstract]   [Full Text] [Related]  

  • 49. Highlights in myeloproliferative neoplasms from the 60th American Society of Hematology Annual Meeting: commentary.
    Mesa RA
    Clin Adv Hematol Oncol; 2019 Jan; 17 Suppl 2(1):18-19. PubMed ID: 31545310
    [No Abstract]   [Full Text] [Related]  

  • 50. Highlights in Hodgkin lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 5(2):1-20. PubMed ID: 35343941
    [No Abstract]   [Full Text] [Related]  

  • 51. Highlights in leukemia and lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 7(2):1-20. PubMed ID: 35343944
    [No Abstract]   [Full Text] [Related]  

  • 52. Highlights in myeloproliferative neoplasms from the 2017 American Society of Hematology Annual Meeting: commentary.
    Verstovsek S
    Clin Adv Hematol Oncol; 2018 Feb; 16 Suppl 4(2):20-23. PubMed ID: 29742090
    [No Abstract]   [Full Text] [Related]  

  • 53. Highlights in CAR T-Cell Therapy in Lymphoma From the 60th American Society of Hematology Annual Meeting: Commentary.
    Locke FL
    Clin Adv Hematol Oncol; 2019 May; 17 Suppl 10(5):20-23. PubMed ID: 32720926
    [No Abstract]   [Full Text] [Related]  

  • 54. Advances in aggressive lymphoma from the 2017 American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2018 Feb; 16 Suppl 5(2):1-24. PubMed ID: 29742097
    [No Abstract]   [Full Text] [Related]  

  • 55. Advances in lymphoma and leukemia from the 2016 American Society of Hematology annual meeting and exposition.
    Clin Adv Hematol Oncol; 2017 Mar; 15 Suppl 3(3):1-24. PubMed ID: 28590461
    [No Abstract]   [Full Text] [Related]  

  • 56. Developments in the treatment of lymphoproliferative disorders: rising to the new challenges of CLL therapy. A report of a symposium presented during the 48th American Society of Hematology Annual Meeting and Exposition, December 8, 2006, Orlando, Florida.
    Clin Adv Hematol Oncol; 2007 Mar; 5(3 Suppl 5):1-14; quiz 15-6. PubMed ID: 17519887
    [No Abstract]   [Full Text] [Related]  

  • 57. The 60th American Society of Hematology Annual Meeting & Exposition.
    Alexander W
    P T; 2019 Mar; 44(3):138-142. PubMed ID: 30828235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent advances in the treatment of multiple myeloma. A Review of Selected Presentations From the 52nd American Society of Hematology Annual Meeting and Exposition.
    Jagannath S
    Clin Adv Hematol Oncol; 2011 Mar; 9(3 Suppl 4):1-16. PubMed ID: 21478821
    [No Abstract]   [Full Text] [Related]  

  • 59. American society of hematology: 56th annual meeting and exposition.
    Alexander W
    P T; 2015 Feb; 40(2):133-5. PubMed ID: 25673964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. American Society of Hematology Annual Meeting and Exposition.
    Alexander W
    P T; 2017 Feb; 42(2):135-139. PubMed ID: 28163560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.